Jian Tan

2.5k total citations
152 papers, 1.7k citations indexed

About

Jian Tan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jian Tan has authored 152 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Surgery and 35 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jian Tan's work include Thyroid Cancer Diagnosis and Treatment (63 papers), Thyroid Disorders and Treatments (28 papers) and Thyroid and Parathyroid Surgery (15 papers). Jian Tan is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (63 papers), Thyroid Disorders and Treatments (28 papers) and Thyroid and Parathyroid Surgery (15 papers). Jian Tan collaborates with scholars based in China, United States and United Kingdom. Jian Tan's co-authors include Zhaowei Meng, Qiang Jia, Guizhi Zhang, Wei Zheng, Wei Li, Renfei Wang, Jin Chang, Zhongyun Liu, Ruiguo Zhang and Feilun Cui and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Scientific Reports.

In The Last Decade

Jian Tan

143 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Tan China 23 683 463 273 250 202 152 1.7k
Takuya Suzuki Japan 22 489 0.7× 664 1.4× 122 0.4× 204 0.8× 542 2.7× 103 2.1k
Cheng–Chia Wu United States 23 429 0.6× 480 1.0× 189 0.7× 101 0.4× 231 1.1× 90 2.3k
Davood Beiki Iran 19 286 0.4× 294 0.6× 554 2.0× 258 1.0× 212 1.0× 136 1.5k
Toyone Kikumori Japan 21 638 0.9× 317 0.7× 81 0.3× 526 2.1× 387 1.9× 82 1.6k
Jianyong Yang China 22 204 0.3× 557 1.2× 80 0.3× 442 1.8× 142 0.7× 77 1.6k
Kensuke Ohta Japan 25 278 0.4× 676 1.5× 111 0.4× 492 2.0× 398 2.0× 104 2.7k
Sun Young Min South Korea 24 180 0.3× 489 1.1× 100 0.4× 403 1.6× 430 2.1× 60 1.7k
Anren Kuang China 18 343 0.5× 168 0.4× 347 1.3× 247 1.0× 104 0.5× 92 1.0k
Tao Huang China 29 793 1.2× 965 2.1× 173 0.6× 499 2.0× 456 2.3× 177 2.6k
Naoko Chayahara Japan 18 287 0.4× 356 0.8× 49 0.2× 172 0.7× 577 2.9× 44 1.4k

Countries citing papers authored by Jian Tan

Since Specialization
Citations

This map shows the geographic impact of Jian Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Tan more than expected).

Fields of papers citing papers by Jian Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Tan. The network helps show where Jian Tan may publish in the future.

Co-authorship network of co-authors of Jian Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Tan. A scholar is included among the top collaborators of Jian Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Tan. Jian Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Heng, et al.. (2025). KLF10-IN-1 Attenuates RPE Cell Apoptosis and Experimental Diabetic Retinopathy Via the KLF10/PERK/eIF2α/ATF4/CHOP Pathway. Investigative Ophthalmology & Visual Science. 66(15). 25–25.
3.
Zheng, Wei, Qiang Jia, Jian Tan, et al.. (2024). Predictive value of bone turnover markers and thyroid indicators for bone metabolism in GD patients after treatment. Frontiers in Endocrinology. 15. 1301213–1301213. 1 indexed citations
4.
Yang, Chen, Zihan Ma, Jian Tan, et al.. (2024). Structural and functional alterations of the hippocampal subfields in T2DM with mild cognitive impairment and insulin resistance: A prospective study. Journal of Diabetes. 16(11). e70029–e70029. 5 indexed citations
5.
Yang, Chen, Lei Yang, Dihua Li, et al.. (2024). Shikonin inhibits the growth of anaplastic thyroid carcinoma cells by promoting ferroptosis and inhibiting glycolysis. Heliyon. 10(14). e34291–e34291. 1 indexed citations
6.
Sun, Ying, Miao Wang, Ruyi Zhang, et al.. (2023). Establishment and Analytical Performance of Light-Initiated Chemiluminescence Assay Method for Detecting Thyrotropin Receptor Antibody. Biomarkers in Medicine. 17(7). 349–357. 2 indexed citations
7.
Li, Ning, Ruyi Zhang, Xue Li, et al.. (2022). Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis. Journal of Healthcare Engineering. 2022. 1–13. 2 indexed citations
8.
Su, Limin, Yongchao Cao, Huimin Li, & Jian Tan. (2022). Blockchain-Driven Optimal Strategies for Supply Chain Finance Based on a Tripartite Game Model. Journal of theoretical and applied electronic commerce research. 17(4). 1320–1335. 15 indexed citations
10.
Zheng, Xiangqian, Zhengang Xu, Qinghai Ji, et al.. (2021). A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer. Clinical Cancer Research. 27(20). 5502–5509. 31 indexed citations
11.
Jin, Jiahui, Chao Huang, Qiang Jia, et al.. (2021). Urinary Iodine Concentration and Radioactive Iodine Therapeutic Response in Patients with Differentiated Thyroid Cancer. Biomarkers in Medicine. 15(11). 879–890. 1 indexed citations
13.
Zheng, Xiangqian, Xianghui He, Chao Huang, et al.. (2020). Prognostic Value and Dynamics of Antithyroglobulin Antibodies for Differentiated Thyroid Carcinoma. Biomarkers in Medicine. 14(18). 1683–1692. 14 indexed citations
14.
15.
16.
Meng, Zhaowei, Michiko Matsuse, Vladimir Saenko, et al.. (2019). TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131i uptake in metastases. IUBMB Life. 71(7). 1030–1040. 22 indexed citations
17.
Li, Ning, Siyuan Feng, Lei Sun, et al.. (2019). An experimental study on the induction of Graves′ hyperthyroidism with Graves′ ophthalmopathy in BALB/c mice by TSHR gene immunization. Zhonghua neifenmi daixie zazhi. 35(5). 417–424. 1 indexed citations
18.
Feng, Siyuan, Wei Zheng, Ruiguo Zhang, et al.. (2018). Clinical characteristics and 131I efficacy of papillary thyroid microcarcinoma and papillary thyroid non-micro carcinoma. 42(2). 111–114. 1 indexed citations
19.
Li, Chen, et al.. (2018). Asset Investment Strategy Adapting Default Service of Incremental Distribution Network for Grid Companies. 42(20). 38–44. 3 indexed citations
20.
Tan, Jian. (2010). Study on fluid-solid coupling in horizontal well and pressure drop in pit shaft. Journal of Liaoning Technical University.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026